Cowen Prime Advisors LLC Pharming Group N.V. Transaction History
Cowen Prime Advisors LLC
- $287 Million
- Q2 2023
A detailed history of Cowen Prime Advisors LLC transactions in Pharming Group N.V. stock. As of the latest transaction made, Cowen Prime Advisors LLC holds 22,460 shares of PHAR stock, worth $189,786. This represents 0.09% of its overall portfolio holdings.
Number of Shares
22,460
Previous 22,460
-0.0%
Holding current value
$189,786
Previous $250,000
4.4%
% of portfolio
0.09%
Previous 0.1%
Shares
8 transactions
Others Institutions Holding PHAR
# of Institutions
6Shares Held
50.1KCall Options Held
0Put Options Held
0-
Silverberg Bernstein Capital Management LLC Armonk, NY41.1KShares$347,3790.31% of portfolio
-
Morgan Stanley New York, NY2.8KShares$23,6590.0% of portfolio
-
Ubs Group Ag789Shares$6,6670.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ568Shares$4,7990.0% of portfolio
-
Concourse Financial Group Securities, Inc. Birmingham, AL0Shares$00.0% of portfolio
About Pharming Group N.V.
- Ticker PHAR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 65,241,400
- Market Cap $551M
- Description
- Pharming Group N.V., a biopharmaceutical company, develops and commercialize protein replacement therapies and precision medicines for the treatment of rare diseases and unmet medical needs in the United States, Europe, and internationally. The company's lead product is Ruconest, a recombinant human C1 esterase inhibitor that is used for the tre...